Author:
Vidisheva Aleksandra P.,Wang James,Spektor Tanya M.,Bitran Jacob D,Lutzky Jose,Tabbara Imad A.,Ye Joseph Z.,Ailawadhi Sikander,Stampleman Laura V.,Steis Ronald G.,Moezi Mehdi M.,Swift Regina A.,Maluso Tina M,Udd Kyle A,Eshaghian Shahrooz,Nassir Youram,Berenson James R.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Hideshima T, Richardson P, Chauhan D, Palombella VJ, Elliott PJ, Adams J (2001) The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Cancer Res 61:3071–3076
2. Nawrocki ST, Carew JS, Dunner K, Boise LH, Chiao PJ, Huang P, Abbruzzese JL, McConkey DJ (2005) Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells. Cancer Res 65:11510–11519
3. Shao L, Wang S, Meng H, Qian W, Mai W, Yu W, Tong H, Mao L, Wei J, Qian J, Jin J (2015) Bortezomib-induced peripheral neuropathy in multiple myeloma patients. Zhonghua Yi Xue Za Zhi 95:3297
4. Richardson PG, Barlogie B, Berenson J, Singhal S, Jagannath S, Irwin D, Rajkumar SV, Srkalovic G, Alsina M, Alexanian R, Siegel D, Orlowski RZ, Kuter D, Limentani SA, Lee S, Hideshima T, Esseltine D, Kauffman M, Adams J, Schenkein DP, Anderson KC (2003) A phase 2 study of bortezomib in relapsed, refractory myeloma. N Engl J Med 348:2609–2617
5. Jagannath S, Barlogie B, Berenson J, Siegel D, Irwin D, Richardson PG, Niesvizky R, Alexanian R, Limentani SA, Alsina M, Adams J, Kauffman M, Esseltine D, Schenkein DP, Anderson KC (2004) A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma. Br J Haematol 127:165–172
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献